In the Era of Cost-Effectiveness Analysis, Affordability Is a Limiting Factor for Patients' Access to Innovative Cancer Treatments

Abstract

In the Era of Cost-Effectiveness Analysis, Affordability Is a Limiting Factor for Patients' Access to Innovative Cancer Treatments

Value Health Reg Issues. 20:47–50.

DOI of original article: 10.1016/j.vhri.2018.12.003

The order of authors was incorrectly listed in the version of this article that was originally published online on March 9, 2019.

The correct author order, which has since been corrected online and now appears correctly in this issue, is: P.N. Aguiar Jr; Jacob J. Adashek; Felipe Roitberg; Carmelia Maria Noia Barreto; Auro Del Giglio; and Gilberto L. Lopes Jr.

Authors

Full Text Cite This Article
Back to Volume 20, Supplemental C
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×